Lessening Organ Dysfunction With VITamin C - COVID

Lamontagne et al., NCT04401150, LOVIT-COVID, NCT04401150, Dec 2022
Vitamin C for COVID-19
6th treatment shown to reduce risk in September 2020, now with p = 0.000000069 from 72 studies, recognized in 22 countries.
Lower risk for mortality, ICU, hospitalization, and recovery.
No treatment is 100% effective. Protocols combine treatments.
6,600+ studies for 220+ treatments. c19early.org
392 patient vitamin C late treatment RCT with results not reported over 3 years after completion. The companion non-COVID trial NCT03680274 (history) has reported results.
6 vitamin C RCTs have results missing long after expected1-6
The trials report a total of 1,420 patients, with 3 trials having actual enrollment of 602, and the remainder estimated.
Lamontagne et al., 6 Dec 2022, Double Blind Randomized Controlled Trial, placebo-controlled, Canada, trial NCT04401150 (history) (LOVIT-COVID).
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
Submit